US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 6.950
  • -0.030-0.43%
Close Dec 13 16:00 ET
  • 7.010
  • +0.060+0.86%
Post 18:36 ET
1.99BMarket Cap-4.51P/E (TTM)

Recursion Pharmaceuticals Key Stats

Recursion Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 6, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
29.83M
26.08M
-3.75M
Miss Est.
+183.19%
+147.62%
-12.56%
EPS
-0.35
-0.34
+0.01
Beat Est.
+18.49%
+20.93%
+2.97%
Buy

Dec 13, 2024

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.975M--
--2024/Q4-- / 18.171M--
Nov 6, 20242024/Q326.082M / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.975M--
--2024/Q4-- / 18.171M--
Nov 6, 20242024/Q326.082M / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 13, 2024

Buy

  • Buy

    40.00%
  • Hold

    60.00%
  • Sell

    0.00%

Price Target

No Data